Literature DB >> 27662896

Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation.

Kevin G Burfeind1, Vijayshree Yadav2, Daniel L Marks3.   

Abstract

Signs and symptoms of multiple sclerosis are usually attributed to demyelinating lesions in the spinal cord or cerebral cortex. The hypothalamus is a region that is often overlooked yet controls many important homeostatic functions, including those that are perturbed in multiple sclerosis. In this review we discuss how hypothalamic dysfunction may contribute to signs and symptoms in people with multiple sclerosis. While dysfunction of the hypothalamic-pituitary-adrenal axis is common in multiple sclerosis, the effects and mechanisms of this dysfunction are not well understood. We discuss three hypothalamic mechanisms of fatigue in multiple sclerosis: (1) general hypothalamic-pituitary-adrenal axis hyperactivity, (2) disordered orexin neurotransmission, (3) abnormal cortisol secretion. We then review potential mechanisms of weight dysregulation caused by hypothalamic dysfunction. Lastly, we propose future studies and therapeutics to better understand and treat hypothalamic dysfunction in multiple sclerosis. Hypothalamic dysfunction appears to be common in multiple sclerosis, yet current studies are underpowered and contradictory. Future studies should contain larger sample sizes and standardize hormone and neuropeptide measurements.

Entities:  

Keywords:  Fatigue; Hypothalamus; Multiple sclerosis; Neuroendocrinology; Weight dysregulation

Mesh:

Year:  2016        PMID: 27662896      PMCID: PMC5502812          DOI: 10.1007/s11910-016-0700-3

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  127 in total

1.  Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters.

Authors:  P Flachenecker; T Kümpfel; B Kallmann; M Gottschalk; O Grauer; P Rieckmann; C Trenkwalder; K V Toyka
Journal:  Mult Scler       Date:  2002-12       Impact factor: 6.312

Review 2.  Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions.

Authors:  Evan Russell; Gideon Koren; Michael Rieder; Stan Van Uum
Journal:  Psychoneuroendocrinology       Date:  2011-10-04       Impact factor: 4.905

Review 3.  Amantadine for fatigue in multiple sclerosis.

Authors:  E Pucci; P Branãs; R D'Amico; G Giuliani; A Solari; C Taus
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

4.  Prevalence of overweight, obesity and metabolic syndrome components in multiple sclerosis patients with significant disability.

Authors:  O Pinhas-Hamiel; M Livne; G Harari; A Achiron
Journal:  Eur J Neurol       Date:  2015-05-14       Impact factor: 6.089

5.  Hypocretin (orexin) loss in Alzheimer's disease.

Authors:  Rolf Fronczek; Sarita van Geest; Marijke Frölich; Sebastiaan Overeem; Freek W C Roelandse; Gert Jan Lammers; Dick F Swaab
Journal:  Neurobiol Aging       Date:  2011-05-05       Impact factor: 4.673

Review 6.  Fatigue in multiple sclerosis: a rational approach to evaluation and treatment.

Authors:  Jay H Rosenberg; Renata Shafor
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

7.  Cortisol secretion is related to electroencephalographic alertness in human subjects during daytime wakefulness.

Authors:  F Chapotot; C Gronfier; C Jouny; A Muzet; G Brandenberger
Journal:  J Clin Endocrinol Metab       Date:  1998-12       Impact factor: 5.958

8.  HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter.

Authors:  Jeroen Melief; Stella J de Wit; Corbert G van Eden; Charlotte Teunissen; Jörg Hamann; Bernard M Uitdehaag; Dick Swaab; Inge Huitinga
Journal:  Acta Neuropathol       Date:  2013-06-28       Impact factor: 17.088

9.  Hypothalamic orexin neurons regulate arousal according to energy balance in mice.

Authors:  Akihiro Yamanaka; Carsten T Beuckmann; Jon T Willie; Junko Hara; Natsuko Tsujino; Michihiro Mieda; Makoto Tominaga; Ken ichi Yagami; Fumihiro Sugiyama; Katsutoshi Goto; Masashi Yanagisawa; Takeshi Sakurai
Journal:  Neuron       Date:  2003-06-05       Impact factor: 17.173

10.  Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients.

Authors:  Emilia Sbardella; Nikolaos Petsas; Francesca Tona; Luca Prosperini; Eytan Raz; Gianvito Pace; Carlo Pozzilli; Patrizia Pantano
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

View more
  8 in total

Review 1.  The Role of Electroacupuncture in the Regulation of Appetite-Controlling Hormone and Inflammatory Response in Obesity.

Authors:  Dinda Aniela Bintoro; Irma Nareswari
Journal:  Med Acupunct       Date:  2021-08-17

Review 2.  Brain Structural and Functional Alterations in Multiple Sclerosis-Related Fatigue: A Systematic Review.

Authors:  Chiara Barbi; Francesca Benedetta Pizzini; Stefano Tamburin; Alice Martini; Anna Pedrinolla; Fabio Giuseppe Laginestra; Gaia Giuriato; Camilla Martignon; Federico Schena; Massimo Venturelli
Journal:  Neurol Int       Date:  2022-06-08

3.  Multiple sclerosis and sarcoidosis: A case for coexistence.

Authors:  Charles Tyshkov; Siddharama Pawate; Michael J Bradshaw; Dorlan J Kimbrough; Tanuja Chitnis; Jeffrey M Gelfand; Lana Zhovtis Ryerson; Ilya Kister
Journal:  Neurol Clin Pract       Date:  2019-06

Review 4.  Mechanisms of Acupuncture Therapy for Simple Obesity: An Evidence-Based Review of Clinical and Animal Studies on Simple Obesity.

Authors:  Li-Hua Wang; Wei Huang; Dan Wei; De-Guang Ding; Yi-Ran Liu; Jia-Jie Wang; Zhong-Yu Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2019-02-03       Impact factor: 2.629

Review 5.  Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions.

Authors:  Alain Couvineau; Thierry Voisin; Pascal Nicole; Valerie Gratio; Anne Blais
Journal:  World J Gastroenterol       Date:  2021-11-28       Impact factor: 5.742

6.  Ketogenic diet uncovers differential metabolic plasticity of brain cells.

Authors:  Tim Düking; Lena Spieth; Stefan A Berghoff; Lars Piepkorn; Annika M Schmidke; Miso Mitkovski; Nirmal Kannaiyan; Leon Hosang; Patricia Scholz; Ali H Shaib; Lennart V Schneider; Dörte Hesse; Torben Ruhwedel; Ting Sun; Lisa Linhoff; Andrea Trevisiol; Susanne Köhler; Adrian Marti Pastor; Thomas Misgeld; Michael Sereda; Imam Hassouna; Moritz J Rossner; Francesca Odoardi; Till Ischebeck; Livia de Hoz; Johannes Hirrlinger; Olaf Jahn; Gesine Saher
Journal:  Sci Adv       Date:  2022-09-16       Impact factor: 14.957

Review 7.  Insights into the Therapeutic Potential of Glucocorticoid Receptor Modulators for Neurodegenerative Diseases.

Authors:  Alejandro F De Nicola; Maria Meyer; Rachida Guennoun; Michael Schumacher; Hazel Hunt; Joseph Belanoff; E Ronald de Kloet; Maria Claudia Gonzalez Deniselle
Journal:  Int J Mol Sci       Date:  2020-03-20       Impact factor: 5.923

Review 8.  Orexin/hypocretinin in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Jean Pierre Pallais; Catherine M Kotz; Milos Stanojlovic
Journal:  Neural Regen Res       Date:  2020-06       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.